Richard C. Young & Co’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$19.6M Buy
77,003
+786
+1% +$183K 1.44% 29
2026
Q1
$18.6M Buy
76,217
+124
+0.2% +$28.9K 1.54% 30
2025
Q4
$15.7M Buy
76,093
+1,216
+2% +$240K 1.41% 36
2025
Q3
$13.9M Hold
74,877
1.29% 35
2025
Q2
$11.4M Buy
74,877
+165
+0.2% +$25.4K 1.13% 39
2025
Q1
$12.4M Buy
74,712
+29
+0% +$4.54K 1.33% 35
2024
Q4
$10.8M Buy
74,683
+467
+0.6% +$72.4K 1.18% 39
2024
Q3
$12M Buy
74,216
+1,237
+2% +$197K 1.31% 40
2024
Q2
$10.7M Buy
72,979
+275
+0.4% +$40.9K 1.3% 42
2024
Q1
$11.5M Buy
72,704
+507
+0.7% +$80.7K 1.44% 37
2023
Q4
$11.3M Buy
72,197
+841
+1% +$129K 1.52% 33
2023
Q3
$11.1M Sell
71,356
-43,035
-38% -$7.1M 1.58% 31
2023
Q2
$18.9M Buy
114,391
+1,672
+1% +$270K 2.6% 7
2023
Q1
$17.5M Sell
112,719
-914
-0.8% -$148K 2.41% 7
2022
Q4
$20.1M Sell
113,633
-252
-0.2% -$43.5K 2.67% 6
2022
Q3
$18.6M Sell
113,885
-169
-0.1% -$28.6K 2.85% 5
2022
Q2
$20.2M Buy
114,054
+1,261
+1% +$225K 2.62% 7
2022
Q1
$20M Sell
112,793
-725
-0.6% -$123K 2.55% 8
2021
Q4
$19.4M Buy
113,518
+1,574
+1% +$258K 2.45% 10
2021
Q3
$18.1M Sell
111,944
-58
-0.1% -$9.89K 2.48% 10
2021
Q2
$18.5M Buy
112,002
+2,244
+2% +$372K 2.34% 10
2021
Q1
$18M Buy
109,758
+4,075
+4% +$659K 2.4% 8
2020
Q4
$16.6M Buy
105,683
+3,793
+4% +$560K 2.53% 9
2020
Q3
$15.2M Buy
101,890
+1,753
+2% +$259K 2.44% 9
2020
Q2
$14.1M Sell
100,137
-403
-0.4% -$58.7K 2.35% 9
2020
Q1
$13.2M Buy
100,540
+1,310
+1% +$186K 2.56% 7
2019
Q4
$14.5M Buy
99,230
+1,585
+2% +$215K 2.41% 13
2019
Q3
$12.6M Buy
97,645
+2,197
+2% +$289K 2.27% 16
2019
Q2
$13.3M Sell
95,448
-754
-0.8% -$104K 2.52% 11
2019
Q1
$13.4M Buy
96,202
+28,802
+43% +$3.86M 2.57% 9
2018
Q4
$8.7M Sell
67,400
-686
-1% -$95.7K 1.86% 19
2018
Q3
$9.41M Sell
68,086
-1,120
-2% -$149K 1.79% 22
2018
Q2
$8.4M Sell
69,206
-451
-0.6% -$56.3K 1.69% 22
2018
Q1
$8.93M Sell
69,657
-2,173
-3% -$294K 1.78% 21
2017
Q4
$10M Sell
71,830
-40,502
-36% -$5.64M 1.89% 20
2017
Q3
$14.6M Sell
112,332
-2,300
-2% -$305K 2.76% 8
2017
Q2
$15.2M Buy
114,632
+874
+0.8% +$111K 2.97% 5
2017
Q1
$14.2M Buy
113,758
+2,806
+3% +$335K 2.8% 7
2016
Q4
$12.8M Buy
110,952
+1,188
+1% +$137K 2.69% 7
2016
Q3
$13M Sell
109,764
-1,690
-2% -$205K 2.8% 5
2016
Q2
$13.5M Sell
111,454
-1,259
-1% -$143K 3% 4
2016
Q1
$12.2M Sell
112,713
-682
-0.6% -$70.6K 2.74% 5
2015
Q4
$11.6M Buy
113,395
+2,458
+2% +$247K 2.65% 5
2015
Q3
$10.4M Sell
110,937
-841
-0.8% -$81.4K 2.56% 5
2015
Q2
$10.9M Sell
111,778
-1,391
-1% -$139K 2.46% 7
2015
Q1
$11.4M Buy
113,169
+1,296
+1% +$132K 2.49% 6
2014
Q4
$11.7M Buy
111,873
+453
+0.4% +$47.7K 2.47% 5
2014
Q3
$11.9M Buy
111,420
+28
+0% +$2.9K 2.54% 6
2014
Q2
$11.7M Buy
111,392
+1,920
+2% +$194K 2.36% 6
2014
Q1
$10.8M Buy
109,472
+349
+0.3% +$32.4K 2.28% 8
2013
Q4
$9.99M Sell
109,123
-902
-0.8% -$83.1K 2.17% 13
2013
Q3
$9.54M Buy
110,025
+879
+0.8% +$78.9K 2.16% 8
2013
Q2
$9.37M Buy
+109,146
New +$9.26M 2.33% 7

Other funds holding JNJ

Richard C. Young & Co's JNJ Position: Q2 2026 in Review

Richard C. Young & Co increased its Johnson & Johnson (JNJ) stake by 1% in Q2 2026, buying an estimated $183K and bringing the position to 77,003 shares worth $19.6M. The position accounts for 1.44% of the portfolio, ranked #29.

Richard C. Young & Co first reported a position in JNJ in Q2 2013 and has held it in 53 quarters since. The position peaked at $20.2M in Q2 2022. 2,012 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Richard C. Young & Co held 77,003 shares of Johnson & Johnson worth $19.6M as of Q2 2026.
  • Richard C. Young & Co bought 786 Johnson & Johnson shares in Q2 2026, an estimated $183K.
  • Johnson & Johnson made up 1.44% of Richard C. Young & Co's portfolio in Q2 2026, its #29 holding.
  • Richard C. Young & Co first reported a position in Johnson & Johnson in Q2 2013 and has held it in 53 quarters since.
  • Richard C. Young & Co's Johnson & Johnson position peaked at $20.2M in Q2 2022.
  • 2,012 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Richard C. Young & Co's 13F filing for Q2 2026, filed 28 Jul 2026.